The global blood pressure monitoring devices market accounted for revenue of US$1.6 Bn in 2020 with a considerable CAGR of 11.4% during the analysis period of 2021 to 2028.
Blood pressure measurement is critical in the diagnosis and monitoring of a wide range of clinical conditions. Home blood pressure monitoring is an important part of managing high or low blood pressure. The American Heart Association (AHA) and other organizations recommend that people with heart disorders should monitor their blood pressure at home. Furthermore, blood pressure monitoring devices are widely available and do not require a prescription, so home monitoring is a simple step toward clinical improvement.
Future of blood pressure monitoring devices will be as easy as taking a video selfie?
Transdermal optical imaging measures blood pressure by detecting blood flow changes in smart phone captured facial videos, according to a report released by the American Heart Association. How is this determined? The digital optical sensors in smart phones can visualize that ambient light that penetrates the layers of outer skin to determine blood flow patterns that transdermal optical imaging models can use to determine blood pressure of the patient. The study included 1,328 Canadian and Chinese adults who were recorded in two-minute videos using an iPhone equipped with transdermal optical imaging software. The study concluded that transdermal optical imaging predicts systolic blood pressure with nearly 95% accuracy and diastolic blood pressure with nearly 96% accuracy. The study demonstrates that facial video can reveal information about systolic blood pressure.
Technological advancement fuel the growth of global blood pressure monitoring devices market
Blood pressure telemonitoring (BPT) has emerged as a promising e-health treatment in the management of hypertension. BPT is a telemedicine strategy that takes patient's self-measured blood pressure (BP) and sends it to healthcare providers via the internet. When compared to standard care without remote monitoring, BPT has been shown to improve blood pressure control. With noticeable technological advancements, remote BP monitoring without the use of a cuff will be possible, resulting in widespread adoption of BPT and ultimately improving patient anatomy by providing physicians with a more complete medical history, potentially resulting in improved BP control and better long-term outcomes.
Growth in cardiac disorders witnessed among the population fuel the demand for blood pressure monitoring devices market worldwide
According to a World Health Organization (WHO) report, cardiovascular diseases (CVDs) are the leading cause of death worldwide, claiming 17.9 million lives each year. Furthermore, according to the American Heart Association report, potential healthcare cost savings with self-measured BP monitoring include reduced office visit follow-ups as a result of improved BP control, avoidance of possible overtreatment in patients with self-measured BP that is lower than office BP, including those with white-coat hypertension, reduction in cardiovascular events, improvement in quality of life, and reduction in lost wages and benefits. Furthermore, it concludes that self-measured BP monitoring is cost effective compared with office BP monitoring or usual care among individuals. Such factors drive the growth of global blood pressure monitoring devices market.
|Market||Blood Pressure Monitoring Devices Market|
|Analysis Period||2017 - 2028|
|Forecast Data||2021 - 2028|
|Segments Covered||By Product, By End Use, and By Geography|
|Regional Scope||North America, Europe, Asia Pacific, Latin America, and Middle East & Africa|
|Key Companies Profiled||Koninklijke Philips N.V., General Electric Company, A&D Company, Limited, Welch Allyn, Inc., SunTech Medical, Inc., American Diagnostic Corporation, Withings, Briggs Medical Service Company, Spacelabs Healthcare, and among others|
||Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis|
10 hrs of free customization and expert consultation
The global blood pressure monitoring devices market is segmented based on product and end-user. By product, the market is segmented as sphygmomanometer/aneroid BP monitors, automated/digital blood pressure monitors, ambulatory blood pressure monitors, transducers, and instruments and accessories. By end-user, the market is segregated as hospitals, ambulatory surgical centers & clinics, and home healthcare.
Based on product, sphygmomanometers/aneroid BP monitors accounted highest revenue share for the forecast period of 2021 to 2028. As the term "aneroid" means "without fluid," and as the name implies, this type of BP apparatus does not use mercury, making it the safest alternative to mercury sphygmomanometers. In addition, aneroid sphygmomanometers, like other blood pressure measuring devices, use a delicate mechanism that requires careful handling. Furthermore, the most significant advantage of using mercury sphygmomanometers is that they are simple to use and, when used properly, can last a lifetime. The device can produce the most precise results with minimal adjustment. These factors have a positive impact on the overall growth of the global blood pressure monitoring devices market.
North America takes a forefront lead in the blood pressure monitoring devices market; Asia Pacific to register fastest growing CAGR for the analysis period of 2021 to 2028
North America holds the lion's share of the market for blood pressure monitoring devices, owing to rising government initiatives involving blood pressure monitoring awareness program, which is one of the key factors driving the regional market's growth. For example, the American Medical Association (AMA) supported integrated health model initiative (IHMI) announced the launch of a data management model in February 2019 with the goal of improving health outcomes. Furthermore, emerging technologies such as mHealth, which promotes treatment as well as medication compliance for patients suffering from chronic diseases, have a positive impact on market expansion.
During the forecast period, Asia Pacific is expected to record an all-time high CAGR for the blood pressure monitoring devices market. Because of the cost effectiveness and accuracy of the results provided by the use of advanced devices, it has received a lot of attention in the APAC region. Furthermore, the government's involvement and support through the "Make in India" initiative aimed at attracting Foreign Direct Investment (FDI) and international players to invest in the Indian market, resulting in the introduction of advanced products. These are the most important factors driving the overall growth of the APAC blood pressure monitoring device market.
As the blood pressure monitoring devices market is experiencing intensive competition it is highly volatile to pricing. The companies are adopting competitive strategies that involve M&A, strategic alliance, partnership, and collaborative agreements, to compete in the market. The prominent players of the global blood pressure monitoring devices market involve Koninklijke Philips N.V., General Electric Company, A&D Company, Limited, Welch Allyn, Inc., SunTech Medical, Inc., American Diagnostic Corporation, Withings, Briggs Medical Service Company, Spacelabs Healthcare, and among others
Market By Product
Market By End-User
Market By Geography
The estimated value of global blood pressure monitoring devices market accounted to be US$1.6 Bn in 2020
The projected CAGR of global blood pressure monitoring devices market accounted to be 11.4% during the analysis period of 2021 to 2028
The exhibited CAGR of global blood pressure monitoring devices market is Asia Pacific